Singular Genomics Systems (NASDAQ: OMIC)
Some price data may be temporarily unavailable.
Singular Genomics Systems Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Singular Genomics Systems Company Info
Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA.
News & Analysis
No articles found.
Valuation
Earnings Transcripts
Singular Genomics Systems, Inc. (OMIC) Q2 2022 Earnings Call Transcript
OMIC earnings call for the period ending June 30, 2022.
Singular Genomics Systems, Inc. (OMIC) Q1 2022 Earnings Call Transcript
OMIC earnings call for the period ending March 31, 2022.
Singular Genomics Systems, Inc. (OMIC) Q4 2021 Earnings Call Transcript
OMIC earnings call for the period ending December 31, 2021.
Singular Genomics Systems, Inc. (OMIC) Q3 2021 Earnings Call Transcript
OMIC earnings call for the period ending September 30, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.